- Home
- PSHG vs IOBT Comparison
PSHG vs IOBT Comparison
Compare PSHG & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.27
HOLD
Current Price
$0.31
Company Overview
Basic Information| Metric | PSHG | IOBT |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | Greece | Denmark |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.8M | 26.6M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PSHG | IOBT |
|---|---|---|
| Price | $2.27 | $0.31 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.25 |
| AVG Volume (30 Days) | 132.0K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.77 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $52.34 | N/A |
| P/E Ratio | $1.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.31 | $0.21 |
| 52 Week High | $2.58 | $2.79 |
Technical Indicators
Market Signals| Indicator | PSHG | IOBT |
|---|---|---|
| Relative Strength Index (RSI) | 55.73 | 39.04 |
| Support Level | $1.77 | $0.26 |
| Resistance Level | $2.58 | $0.40 |
| Average True Range (ATR) | 0.16 | 0.03 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 50.28 | 3.24 |
Price Performance
Historical Comparison PSHG
IOBT
About PSHG Performance Shipping Inc.
Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.